You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
NEW YORK (GenomeWeb News) – Sequenom will build a molecular diagnostics clinical laboratory in North Carolina, creating 242 jobs, the office of North Carolina Gov. Bev Perdue announced today.
NEW YORK (GenomeWeb News) – Sequenom announced today that it has partnered with LifeCodexx to provide prenatal laboratory testing services in Europe.
The company, once called US Genomics, will use the funds to complete development of its first commercial systems for identifying pathogens in complex biological samples.
The firms have begun a validation sudy of the Down syndrome test, which runs on Illumina’s HiSeq platform.
Illumina will provide its DNA analysis technology, Barts will supply tissue samples, and Source BioScience will develop the test.
The company will investigate the use of PacBio's RS platform for use in the test protocol.
After verifying that organ transplant rejection corresponds to a rise in cell-free donor DNA in recipient blood samples, researchers from Stanford University developed a sequencing-based approach for assessing these donor DNA levels.
The startup will use its using next-generation sequencing-based technology for applications aimed at identifying biothreats.
A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.
US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.
According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.
In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.